Scott+Scott Attorneys at Law has filed a securities class action lawsuit against Aevex Corp., its directors, officers, and IPO underwriters. The suit alleges that they made false and misleading statements about a pre-arranged plan to waive the 180-day lock-up period following Aevex's April 2026 IPO. When the market discovered the truth in June 2026, Aevex's stock price fell sharply. Investors who bought Aevex shares during the class period or through the IPO may join the lawsuit or seek lead plaintiff status by October 20, 2026.
Wedbush increased its price target for Scholar Rock to $64 from $58 and kept an "Outperform" rating ahead of the FDA's September 30 decision on Scholar Rock's investigational SMA drug, apitegromab. This drug could be the first muscle-targeted therapy...
IM Cannabis Corp., a medical cannabis company operating in Israel and Germany, will conduct a 1-for-30 reverse stock split on August 27, 2026. This move aims to increase its share price, currently at $0.11, to meet the Nasdaq Capital Market's minimum...
Buckle, Inc. reported strong Q2 earnings with an EPS of $0.87, surpassing analyst estimates of $0.81, and revenue of $319.82 million, slightly above expectations. The company saw a 4.6% increase in net sales, driven by growth in both comparable-store...
KE Holdings Inc. reported Q2 2026 earnings with an EPS of $0.42, surpassing the $0.31 consensus estimate. Although revenue declined 5.7% year-over-year to about $3.60 billion, the company doubled its net income thanks to effective cost controls and o...
Tesla delivered a record 480,126 vehicles but saw its operating margin drop to 1.4% amid heavy investment in R&D and new projects like Optimus and AI compute. Meanwhile, SpaceX, after its $85.7 billion IPO, grew revenue by 92% year-over-year, driven ...
